ABSTRACT
COVID-19 is a disease caused by the virus, SARS-CoV-2, and it can affect individuals differently. Some people may experience mild symptoms while others may experience severe illness or death. Vaccines that are authorized to protect against COVID-19 help the human body develop immunity to SARS-CoV-2 and reduce the risk of COVID-19 and its potentially serious complications. We evaluated the effects of graduated exposure and differential reinforcement to teach individuals with autism to comply with the administration of a COVID-19 vaccine. All three participants had a history of engaging in challenging behavior during previous vaccination procedures. Following the intervention, all participants successfully received two doses of a COVID-19 vaccine. The results of this study support previous research on graduated exposure and differential reinforcement as a treatment for increasing compliance with medical procedures for individuals with autism. (PsycInfo Database Record (c) 2023 APA, all rights reserved)
ABSTRACT
COVID-19 is a disease caused by the virus, SARS-CoV-2, and it can affect individuals differently. Some people may experience mild symptoms while others may experience severe illness or death. Vaccines that are authorized to protect against COVID-19 help the human body develop immunity to SARS-CoV-2 and reduce the risk of COVID-19 and its potentially serious complications. We evaluated the effects of graduated exposure and differential reinforcement to teach individuals with autism to comply with the administration of a COVID-19 vaccine. All three participants had a history of engaging in challenging behavior during previous vaccination procedures. Following the intervention, all participants successfully received two doses of a COVID-19 vaccine. The results of this study support previous research on graduated exposure and differential reinforcement as a treatment for increasing compliance with medical procedures for individuals with autism. (PsycInfo Database Record (c) 2022 APA, all rights reserved)
ABSTRACT
Adults with intellectual and developmental disabilities (AIDD) experience significant oral health disparities, partially due to perceived behavioral issues. This article describes the preliminary outcomes of a developing interdisciplinary (dental, medical, behavioral) program involving a behavioral intervention for AIDD previously receiving preventative dental care with sedation, general anesthesia, or protective stabilization (SAS). After a baseline assessment, a board-certified behavior analyst implemented increasingly complex behavioral interventions during simulated dental visits. Prior to COVID-19 pandemic-related restrictions, there were 32 active participants; 15 (46.9%) successfully completed a focused, real dental exam with simple behavioral interventions and 17 (53.1%) remain in treatment. These preliminary results suggest that many AIDD previously receiving SAS may participate in a preventative dental exam with minimal behavioral supports, if given the opportunity.
Subject(s)
COVID-19 , Intellectual Disability , Adult , Child , Humans , Developmental Disabilities/therapy , Pandemics , Dental CareABSTRACT
During the COVID-19 outbreak, the Center for Disease Control (CDC) recommended that everyone 2 years and older wear a face mask while in a community setting. However, children with autism may be reluctant to wear a mask, particularly for extended durations. In the current study, we implemented a graduated exposure procedure to teach mask wearing for a minimum of 1 hour in an early intensive behavioral (EIBI) intervention clinic to three children diagnosed with autism. We subsequently probed mask wearing, and if necessary implemented the graduated exposure procedure, in each participant's home and in a mock physician's office. Finally, we collected probe data on mask wearing in another community setting and 1 month post-treatment maintenance data in the EIBI clinic. During baseline, participants wore masks for 0 second to 5 minutes. After treatment, all participants wore the mask for at least 1 hour in each setting, with maintenance probes indicating 4 to 5 hour mask tolerance.
Subject(s)
Autistic Disorder , COVID-19 , Autistic Disorder/therapy , Child , Humans , Masks , SARS-CoV-2ABSTRACT
Healthcare professionals and government officials have advised the use of personal protective equipment, such as face masks and face shields, to assist with limiting the spread of the SARS-CoV-2 (COVID-19). Due to the prevalence of challenging behavior associated with other medical routines, the present study evaluated a treatment package composed of graduated exposure, prompts, reinforcement, and escape extinction on tolerance of wearing a face covering for up to 5 min for 12 children with ASD in a systematic replication of Cox et al. (2017) and Sivaraman et al. (2020). We also extended previous research by measuring generalization of face covering type (i.e., face shield) and the efficacy of a treatment extension for tolerating a face covering for up to 15 min during the participants' trial-based instruction and play periods.